Skip to main content

Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men

European Journal of Epidemiology volume 31, pages 853–865 (2016)Cite this article

Abstract

Tea is the most ancient and popular beverage in the world, and its beneficial health effects has attracted tremendous attention worldwide. However, the prospective evidence relating green tea consumption to total and cause-specific mortality is still limited and inconclusive. We recruited 164,681 male participants free of pre-existing disease during 1990–1991, with green tea consumption and other covariates assessed by the standardized questionnaire and mortality follow up continued until 2006 (mean 11 years; total person-years: 1,961,791). Cox regression analyses were used to quantify the associations of green tea consumption with all-cause (n = 32,700), CVD (n = 11,839) and cancer (n = 7002) mortality, adjusting simultaneously for potential confounders. At baseline, 18 % reported regular consumption of green tea. Compared with non-green tea drinkers, regular drinkers had significantly lower all-cause mortality, with adjusted hazard ratios (HRs) being 0.94 (95 % CI 0.89, 0.99) for ≤5 g/day, 0.95 (0.91, 0.99) for 5–10 g/day and 0.89 (0.85, 0.93) for >10 g/day. For CVD mortality, the corresponding HRs were 0.93 (0.85, 1.01) 0.91 (0.85, 0.98) and 0.86 (0.79, 0.93), respectively, while for cancer they were 0.86 (0.78, 0.98), 0.92 (0.83, 1.00) and 0.79 (0.71, 0.88), respectively. The patterns of these associations varied by smoking, alcohol drinking and locality. This large prospective study shows that regular green tea consumption is associated with significantly reduced risk of death from all-cause, CVD and cancer among Chinese adults.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Hayat K, Iqbal H, Malik U, Bilal U, Mushtaq S. Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2013;55(7):939–54.

    Article  Google Scholar 

  2. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21:334–50.

    CAS  Article  PubMed  Google Scholar 

  3. Tong X, Taylor AW, Giles L, Wittert GA, Shi Z. Tea consumption is inversely related to 5-year blood pressure change among adults in Jiangsu, China: a cross-sectional study. Nutr J. 2014;13:98.

    Article  PubMed  PubMed Central  Google Scholar 

  4. http://www.teausa.com/teausa/images/Tea%20Fact%20Sheet%20FINAL.pdf.

  5. http://www.uschina.usc.edu/w_usci/showarticle.aspx?articleID=17471&AspxAutoDetectCookieSupport=1.

  6. Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein AM, Taylor PR. Jasmine tea consumption and upper gastrointestinal cancer in china. Cancer Causes Control. 2009;20:1997–2007.

    Article  PubMed  PubMed Central  Google Scholar 

  7. http://www.tjpr.org/vol6_no3/638Sharma.pdf.

  8. Katiyar SK, Elmets CA. Green tea polyphenolic antioxidants and skin photoprotection (review). Int J Oncol. 2001;18:1307–13.

    CAS  PubMed  Google Scholar 

  9. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. 1997;37:693–704.

    CAS  Article  PubMed  Google Scholar 

  10. Stangl V, Lorenz M, Stangl K. The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res. 2006;50:218–28.

    CAS  Article  PubMed  Google Scholar 

  11. Khan N, Mukhtar H. Tea and health: studies in humans. Curr Pharm Des. 2013;19:6141–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. Blumberg JB. Introduction to the proceedings of the fifth international scientific symposium on tea and human health. Am J Clin Nutr. 2013;98:1607S–10S.

    CAS  Article  PubMed  Google Scholar 

  13. Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr. 1996;50:28–32.

    CAS  PubMed  Google Scholar 

  14. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med. 2003;163:1448–53.

    CAS  Article  PubMed  Google Scholar 

  15. Nagaya N, Yamamoto H, Uematsu M, Itoh T, Nakagawa K, Miyazawa T, Kangawa K, Miyatake K. Green tea reverses endothelial dysfunction in healthy smokers. Heart. 2004;90:1485–6.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. Erba D, Riso P, Bordoni A, Foti P, Biagi PL, Testolin G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem. 2005;16:144–9.

    CAS  Article  PubMed  Google Scholar 

  17. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity. 2007;15:1473–83.

    CAS  Article  PubMed  Google Scholar 

  18. Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med. 2004;164:1534–40.

    Article  PubMed  Google Scholar 

  19. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ. 1995;310:693–6.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. Sato Y, Nakatsuka H, Watanabe T, Hisamichi S, Shimizu H, Fujisaku S, Ichinowatari Y, Ida Y, Suda S, Kato K, et al. Possible contribution of green tea drinking habits to the prevention of stroke. Tohoku J Exp Med. 1989;157:337–43.

    CAS  Article  Google Scholar 

  21. Nakachi K, Matsuyama S, Miyake S, Suganuma M, Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. BioFactors. 2000;13:49–54.

    CAS  Article  PubMed  Google Scholar 

  22. Iwai N, Ohshiro H, Kurozawa Y, Hosoda T, Morita H, Funakawa K, Okamoto M, Nose T. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002;12:191–8.

    Article  PubMed  Google Scholar 

  23. Suzuki E, Yorifuji T, Takao S, Komatsu H, Sugiyama M, Ohta T, Ishikawa-Takata K. Doi H Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol. 2009;19:732–9.

    Article  PubMed  Google Scholar 

  24. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A, Group JS. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in japanese men and women. J Epidemiol Community Health. 2011;65:230–40.

    Article  PubMed  Google Scholar 

  25. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 2008;138:1548S–53S.

    CAS  PubMed  Google Scholar 

  26. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in japan: the ohsaki study. JAMA. 2006;296:1255–65.

    CAS  Article  PubMed  Google Scholar 

  27. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, Boer JM, Grobbee DE, Verschuren WM, Beulens JW. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30:1665–71.

    Article  PubMed  Google Scholar 

  28. Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2014;30(2):103–13.

    Article  PubMed  Google Scholar 

  29. Ruan R, Feng L, Li J, Ng TP, Zeng Y. Tea consumption and mortality in the oldest-old chinese. J Am Geriatr Soc. 2013;61:1937–42.

    Article  PubMed  Google Scholar 

  30. Ivey KL, Lewis JR, Prince RL, Hodgson JM. Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women. Br J Nutr. 2013;110:1648–55.

    CAS  Article  PubMed  Google Scholar 

  31. Qiu L, Sautter J, Gu D. Associations between frequency of tea consumption and health and mortality: evidence from old chinese. Br J Nutr. 2012;108:1686–97.

    CAS  Article  PubMed  Google Scholar 

  32. Leurs LJ, Schouten LJ, Goldbohm RA, van den Brandt PA. Total fluid and specific beverage intake and mortality due to ihd and stroke in the netherlands cohort study. Br J Nutr. 2010;104:1212–21.

    CAS  Article  PubMed  Google Scholar 

  33. Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. Cancer prevention by tea: evidence from laboratory studies. Pharmacol Res. 2011;64:113–22.

    CAS  Article  PubMed  Google Scholar 

  34. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009;3:CD005004.

    PubMed  Google Scholar 

  35. Yang CS, Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr. 2013;33:161–81.

    CAS  Article  PubMed  Google Scholar 

  36. Lambert JD. Does tea prevent cancer? Evidence from laboratory and human intervention studies. Am J Clin Nutr. 2013;98:1667S–75S.

    CAS  Article  PubMed  Google Scholar 

  37. Niu SR, Yang GH, Chen ZM, Wang JL, Wang GH, He XZ, Schoepff H, Boreham J, Pan HC, Peto R. Emerging tobacco hazards in china: 2. Early mortality results from a prospective study. BMJ. 1998;317:1423–4.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. Saito E, Inoue M, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Noda M, Iso H, Tsugane S, Group JS. Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan public health center-based prospective study (JPHC study). Ann Epidemiol. 2015;25:512–8.

    Article  PubMed  Google Scholar 

  39. Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30:103–13.

    CAS  Article  PubMed  Google Scholar 

  40. Pang J, Zhang Z, Zheng TZ, Bassig BA, Mao C, Liu X, Zhu Y, Shi K, Ge J, Yang YJ, Dejia-Huang, Bai M, Peng Y. Green tea consumption and risk of cardiovascular and ischemic related diseases: a meta-analysis. Int J Cardiol. 2016;202:967–74. doi:10.1016/j.ijcard.2014.12.176.

    Article  PubMed  Google Scholar 

  41. Tang J, Zheng JS, Fang L, Jin Y, Cai W, Li D. Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr. 2015;114:673–83.

    CAS  Article  PubMed  Google Scholar 

  42. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a japanese population. Prev Med. 1997;26:769–75.

    CAS  Article  PubMed  Google Scholar 

  43. Nakachi K, Eguchi H, Imai K. Can teatime increase one’s lifetime? Ageing Res Rev. 2003;2:1–10.

    Article  PubMed  Google Scholar 

  44. Gardener H, Rundek T, Wright CB, Elkind MS, Sacco RL. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr. 2013;143:1299–308.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  45. Office ESCP. Cardiopulse: drinking tea reduces non-cardiovascular mortality by 24%. Eur Heart J. 2015;36:706–7.

    Google Scholar 

  46. Yang CS, Lambert JD, Sang S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch Toxicol. 2009;83:11–21.

    CAS  Article  PubMed  Google Scholar 

  47. Huang WY, Lin YR, Ho RF, Liu HY, Lin YS. Effects of water solutions on extracting green tea leaves. Sci World J. 2013;2013:368350.

    Google Scholar 

  48. Onakpoya I, Spencer E, Heneghan C, Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2014;24:823–36.

    CAS  Article  PubMed  Google Scholar 

  49. Senanayake SN. Green tea extract: chemistry, antioxidant properties and food applications—a review. J Funct Foods. 2013;5:1529–41.

    Article  Google Scholar 

  50. Schneider C, Segre T. Green tea: potential health benefits. Am Fam Physician. 2009;79:591–4.

    PubMed  Google Scholar 

  51. Lin D, Tu Y, Zhu L. Concentrations and health risk of polycyclic aromatic hydrocarbons in tea. Food Chem Toxicol. 2005;43:41–8.

    CAS  Article  PubMed  Google Scholar 

  52. Schwalfenberg G, Genuis SJ, Rodushkin I. The benefits and risks of consuming brewed tea: beware of toxic element contamination. J Toxicol. 2013;2013:370460.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, Rannug A, Tornqvist M, Victorin K, Westerholm R. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect. 2002;110(Suppl 3):451–88.

    CAS  Article  PubMed Central  Google Scholar 

  54. Ding YS, Yan XJ, Jain RB, Lopp E, Tavakoli A, Polzin GM, Stanfill SB, Ashley DL, Watson CH. Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from US Brand and non-US Brand cigarettes. Environ Sci Technol. 2006;40:1133–8.

    CAS  Article  PubMed  Google Scholar 

  55. Tithof PK, Elgayyar M, Cho Y, Guan W, Fisher AB, Peters-Golden M. Polycyclic aromatic hydrocarbons present in cigarette smoke cause endothelial cell apoptosis by a phospholipase A2-dependent mechanism. FASEB J. 2002;16:1463–4.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The original survey and subsequent follow-up were supported by the Chinese Ministry of Health; the UK Medical Research Council, British Heart Foundation and Cancer Research UK; the World Bank loan to China; and the Canadian International Development Research Centre. We thank Gonghao Wang and Xinzhou He for their collaboration in the initial survey, the China DSP staff for their continuing effort and cooperation with long-term follow-up of study participants, and Peilong Liu, Chunming Chen, Richard Bumgarner, and Don de Savigny for help getting funding for the initial survey. Dr. Shiwei Liu was supported by a postdoctoral fellowship from the Sino-British fellowship trust. We would also give our special thanks to Dr. Barbara Bolt at the University of South Carolina for assistance in revision of this manuscript.

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA

    Junxiu Liu

  2. National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

    Shiwei Liu & Maigeng Zhou

  3. Division of Statistics, Northern Illinois University, Dekalb, IL, USA

    Haiming Zhou

  4. Department of Statistics, University of South Carolina, Columbia, SC, USA

    Timothy Hanson

  5. Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3-7LF, UK

    Shiwei Liu, Ling Yang & Zhengming Chen

Authors
  1. Junxiu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiwei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haiming Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Timothy Hanson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ling Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhengming Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Maigeng Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maigeng Zhou.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Figure 1a

Spline curves for the multivariate-adjusted association of green tea consumption and CVD mortality across whole population, current smokers and never smokers. (TIFF 407 kb)

Supplemental Figure 1b

Spline curves for the multivariate-adjusted association of green tea consumption and CVD mortality across whole population, non-regular alcohol drinkers, moderate alcohol drinkers and heavy drinkers. (TIFF 408 kb)

Supplemental Figure 1c

Spline curves for the multivariate-adjusted association of green tea consumption and CVD mortality across whole population, urban residents and rural residents. (TIFF 401 kb)

Supplemental Figure 2a

Spline curves for the multivariate-adjusted association of green tea consumption and cancer mortality across whole population, current smokers and never smokers. (TIFF 411 kb)

Supplemental Figure 2b

Spline curves for the multivariate-adjusted association of green tea consumption and cancer mortality across whole population, non-regular alcohol drinkers, moderate alcohol drinkers and heavy drinkers. (TIFF 421 kb)

Supplemental Figure 2c

Spline curves for the multivariate-adjusted association of green tea consumption and cancer mortality across whole population, urban residents and rural residents. (TIFF 400 kb)

Supplementary material 7 (DOCX 15 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Liu, S., Zhou, H. et al. Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men. Eur J Epidemiol 31, 853–865 (2016). https://doi.org/10.1007/s10654-016-0173-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-016-0173-3

Keywords

  • Green tea consumption
  • Mortality
  • Cardiovascular disease
  • Cancer
  • Smoking
  • Alcohol drinking